Mucormycosis (zygomycosis) in a heart-kidney transplant recipient: recovery after posaconazole therapy.
about
Novel perspectives on mucormycosis: pathophysiology, presentation, and management.Posaconazole: an oral triazole with an extended spectrum of activityRhino-orbitocerebral mucormycosis caused by Apophysomyces elegans.Newly discovered neutral glycosphingolipids in aureobasidin A-resistant zygomycetes: Identification of a novel family of Gala-series glycolipids with core Gal alpha 1-6Gal beta 1-6Gal beta sequences.Rapid susceptibility testing of medically important zygomycetes by XTT assay.Genetic identification of the main opportunistic Mucorales by PCR-restriction fragment length polymorphism.Epidemiology and outcome of zygomycosis: a review of 929 reported cases.Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases.A proven case of cutaneous rhizopus infection presenting with severe limb pain very soon after induction treatment in a patient with acute lymphoblastic leukemia.PCR based identification and discrimination of agents of mucormycosis and aspergillosis in paraffin wax embedded tissue.Concurrent pulmonary zygomycosis and Mycobacterium tuberculosis infection: a case reportImproved outcome of zygomycosis in patients with hematological diseases?Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus.Recent advances in antifungal pharmacotherapy for invasive fungal infections.Treatment of invasive infections due to rare or emerging yeasts and moulds.Newer triazole antifungal agents: pharmacology, spectrum, clinical efficacy and limitations.Antifungal prophylaxis among allogeneic hematopoietic stem cell transplant recipients: current issues and new agents.Non-fatal gastric mucormycosis in a renal transplant patient and review of the literature.Posaconazole as salvage therapy in a patient with disseminated zygomycosis: case report and review of the literature.The emergence of mucormycosis as an important opportunistic fungal infection: five cases presenting to a tertiary referral center for mycology.Posaconazole: a new broad-spectrum antifungal agent.Efficacy of liposomal amphotericin B and posaconazole in intratracheal models of murine mucormycosis.Nosocomial post-traumatic cutaneous mucormycosis: a systematic review.Invasive mucormycosis in a patient with liver cirrhosis: case report and review of the literatureInvasive mold infections: recent advances in management approaches.Healthcare-associated mucormycosis.Rhino-orbital-cerebral mucormycosis.Posaconazole plasma concentration in pediatric patients receiving antifungal prophylaxis after allogeneic hematopoietic stem cell transplantation.Evaluation of 28 cases of mucormycosis.Correlation of in vitro activity, serum levels, and in vivo efficacy of posaconazole against Rhizopus microsporus in a murine disseminated infection.Mucormycosis infection following intravenous access in the forearm.Efficacy of liposomal amphotericin B combined with gamma interferon or granulocyte-macrophage colony-stimulating factor for treatment of systemic zygomycosis in mice.Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections.Acute Cardiac Failure due to Intra-Atrial Mass Caused by Zygomycetes in an Immunocompromised Paediatric Patient.Use of posaconazole in the treatment of infective rhinocerebral mucormycosis.Posaconazole salvage therapy allows successful allogeneic hematopoietic stem cell transplantation in patients with refractory invasive mold infections.[Pulmonary zygomycosis--a rare angioinvasive fungal infection].The first case of cutaneous mucormycosis caused by Rhizopus azygosporus.Pharmacokinetics of oral posaconazole in allogeneic hematopoietic stem cell transplant recipients with graft-versus-host disease.A case of peritonitis caused by Rhizopus microsporus.
P2860
Q24530554-6AC45D44-267D-45CC-801A-C8C91DE716D9Q28291282-97D76123-1E69-4100-8442-0E43529108F3Q31033645-FD58C677-83F1-4303-A6DD-CE11D9290BDEQ31064219-26636C90-0EC9-4185-94E0-8AF6E36F8560Q34430832-31A9CC63-1C5D-41AA-9B8E-7D29763FA2B9Q34431828-2647306A-22D3-4432-BF4A-C7777DE4B3D5Q34440240-5257BCD4-CCFB-48C8-97E1-8D882A5C96C5Q34498982-CE9A6DC2-D21E-4ACB-8CF3-CCF5F55FBD69Q35133141-4C420149-036F-4DD3-8BAF-DF1614D29660Q35588822-AB06E9B6-384E-4457-9954-E11850628C5CQ35791261-F7A6ED94-0AED-4CF2-9A2C-5D04DC37B306Q35883785-D6011069-EA6B-4BAF-AA4F-102D6192F064Q35912243-F781DFBD-2D0D-49DC-8F0F-B0D2F417A21EQ35917383-63C5D4C5-534F-4556-B7C9-7C4386AC372EQ36491806-BE703D95-E462-479E-A843-2C0458F90EA8Q36491819-25099BF2-2DAD-4A15-9D95-0F98F1599110Q36505508-69E22A33-29C1-4295-95BB-DA8F5AB0BD92Q36658244-DEBC9649-90C0-44FC-ADCE-C396E2769EB7Q36718486-39439C06-5B2B-4EE7-8E22-9031C3BCECF6Q36794895-E773AB5C-A3BD-4334-87EB-FB64B9102927Q36828159-16DF0EC9-5236-43CD-BC3A-397846380B83Q36969836-3315F911-D3CF-43F0-BF54-4878AB74CE96Q37201585-61D0E052-1FBD-4EF7-9782-F75AA4C00806Q37261755-1DAB5590-3E3D-4BE6-961E-7F34A5EC876FQ37428946-8210950D-2292-4E9D-9DD5-F411E4A46E42Q37976049-E1888FA4-C1EC-4966-9DF0-8D5D0D27C301Q38017577-AEE6C6C3-4D74-46E0-90E3-2C3B2DC73D12Q40413232-22E11771-D51F-498F-9F29-F072D91BF3C7Q41543392-FF0171F7-541A-4AB8-962D-F419DB20896EQ41850557-468A73E8-7FCC-499C-B73B-A98990C9ED34Q42021604-9656E5D5-142C-483F-9855-8F177C2E7FB2Q42095363-4377AB0F-5295-466F-A3BD-1E47AA50D4C0Q42686004-A307A0E1-FAE0-460E-A6BE-C783FA2E0972Q42703857-93EF704C-B335-4F8E-970C-105B2EE496BBQ43101266-C418D38E-829A-461D-8279-AAFB5ADE431FQ43756553-DD1D9158-31E7-44C2-BE53-5886AB272293Q46434507-C5E1D221-1A15-405F-9DAD-CF83F56246E8Q46640063-C56DA16E-E633-4D19-BCEA-BB4194C9E0D8Q46879963-F114CFAA-66AD-42FF-8DF9-7D7C3DBF9FDBQ46934289-12A75FF8-FC81-4A2E-8973-7B6400B4965A
P2860
Mucormycosis (zygomycosis) in a heart-kidney transplant recipient: recovery after posaconazole therapy.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Mucormycosis (zygomycosis) in ...... ry after posaconazole therapy.
@en
type
label
Mucormycosis (zygomycosis) in ...... ry after posaconazole therapy.
@en
prefLabel
Mucormycosis (zygomycosis) in ...... ry after posaconazole therapy.
@en
P2093
P2860
P356
P1476
Mucormycosis (zygomycosis) in ...... ry after posaconazole therapy.
@en
P2093
Angela Ma Tobón
Angela Restrepo
Darío Fernández
Myrtha Arango
P2860
P304
P356
10.1086/375075
P407
P577
2003-05-16T00:00:00Z